<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00156221</url>
  </required_header>
  <id_info>
    <org_study_id>METC UMC Utrecht 99/184</org_study_id>
    <nct_id>NCT00156221</nct_id>
  </id_info>
  <brief_title>MR Scanning of Very Young Children With Severe Developmental Disorders</brief_title>
  <official_title>MR Scanning of Very Young Children With Severe Developmental Disorders (Autistic Spectrum Disorders and/or Mental Retardation and/or Language Disorders)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Netherlands Organisation for Scientific Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Dutch Brain Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UMC Utrecht</source>
  <brief_summary>
    <textblock>
      The specific is to study the MR morphologic and spectroscopic brain correlates and predictors&#xD;
      of development in children with severe developmental disorders (autistic spectrum disorders&#xD;
      and/or mental retardation and/or language disorders). Given the frequently observed&#xD;
      association of autism with known medical conditions, particularly in cases with comorbid&#xD;
      mental retardation and in cases with atypical autism (Rutter et al., 1994; Gillberg, 1995),&#xD;
      children with suspected autism or related developmental disorders will be asked to&#xD;
      participate in an extensive state of the art laboratory work-up which includes T1 and T2&#xD;
      weighted MRI of the brain. MRI data will be analyzed both qualitatively, looking for focal&#xD;
      abnormalities and degree of myelination, and quantitatively, measuring volumes of total&#xD;
      brain, cerebellum, ventricles and grey and white matter. For research purposes, the work-up&#xD;
      will be supplied with proton Magnetic Resonance Spectroscopy (MRS) of the brain. This data&#xD;
      set provides the opportunity to chart brain-behavior relationships in young children with&#xD;
      suspected autism and related PDD cross-sectionally.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2000</start_date>
  <completion_date>September 2005</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Natural History</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <condition>Autism</condition>
  <condition>Mental Retardation</condition>
  <condition>Language Disorder</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 months to 7 years&#xD;
&#xD;
          -  Diagnosis of autism spectrum disorder, a language disorder or mental retardation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant motor or sensory impairment&#xD;
&#xD;
          -  Major physical abnormalities&#xD;
&#xD;
          -  History of serious head injury&#xD;
&#xD;
          -  Identifiable neurologic disorder&#xD;
&#xD;
          -  Metal implants&#xD;
&#xD;
          -  Contraindication for MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Herman van Engeland, PhD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mijke Zeegers, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3508 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>September 8, 2005</last_update_submitted>
  <last_update_submitted_qc>September 8, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2005</last_update_posted>
  <keyword>Autism</keyword>
  <keyword>MRI</keyword>
  <keyword>Developmental Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intellectual Disability</mesh_term>
    <mesh_term>Language Disorders</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Developmental Disabilities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

